2m 2m 2m 2m 2m 2m 2m
iRhythm Hldg (IRTC)
NASDAQ
$110.34+$5.64 (+5.39%)
Price as of Jun 23, 2026 4:23 PM EDT- $3.4BMarket Cap
- -30.65%1-Year Change
- Medical DevicesIndustry
iRhythm Hldg (IRTC)
$110.34+$5.64 (+5.39%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 747.1M +26.24% | 591.8M +20.13% | 492.7M +19.90% | 410.9M +27.29% | |
Cost of Revenue | 219.9M +19.30% | 184.3M +14.57% | 160.9M +24.43% | 129.3M +18.33% | |
Gross Profit | 527.3M +29.38% | 407.5M +22.82% | 331.8M +17.82% | 281.6M +31.87% | |
Sales and Marketing Expense | 492.6M +17.68% | 418.6M +8.54% | 385.6M +19.69% | 322.2M +17.23% | |
Research and Development Expense | -84.6M +18.40% | -71.5M +18.62% | -60.2M -229.25% | 46.6M +20.53% | |
Depreciation and Amortization Expense | 20.7M +0.13% | 20.7M +26.71% | 16.3M +21.95% | 13.4M +36.20% | |
Total Operating Expenses | 584.7M +11.78% | 523.0M +14.46% | 457.0M +15.57% | 395.4M +26.13% | |
Operating Profit | -57.4M -50.30% | -115.5M -7.71% | -125.2M +10.00% | -113.8M +13.85% | |
Interest Income | 21.5M -1.90% | 21.9M N/A | N/A N/A | N/A N/A | |
Interest Expense | -13.1M +20.53% | -10.9M +198.16% | -3.6M -11.79% | -4.1M +253.98% | |
Interest Income and Expense and Net | 8.4M -23.98% | 11.1M +402.88% | -3.6M -188.21% | 4.1M +253.98% | |
Total Nonoperating Income and Expense | 13.8M +396.55% | 2.8M -54.82% | 6.2M +202.31% | 2.0M +1,625.42% | |
Income before Taxes | -43.6M -61.32% | -112.7M -8.10% | -122.7M +5.84% | -115.9M +14.75% | |
Income Taxes | 953,000 +68.67% | 565,000 -24.67% | 750,000 +178.81% | 269,000 -26.70% | |
Extraordinary Items | 4.5M +595.48% | 641,000 -94.21% | 11.1M -52.18% | 23.2M N/A | |
Net Income | -44.6M -60.67% | -113.3M -8.20% | -123.4M +6.24% | -116.2M +14.60% | |
Net Income from Continuing Operations Applicable to Common | -43.6M -61.32% | -112.7M -8.10% | -122.7M +5.84% | -115.9M +14.75% | |
Basic EPS and Net Income | -1.39 -61.71% | -3.63 -10.15% | -4.04 +4.12% | -3.88 +12.14% | |
Diluted EPS and Net Income | -1.39 -61.71% | -3.63 -10.15% | -4.04 +4.12% | -3.88 +12.14% | |
Basic Weighted Average Shares | 32.0M +2.59% | 31.2M +2.19% | 30.5M +2.05% | 29.9M +1.99% | |
Diluted Weighted Average Shares | 32.0M +2.59% | 31.2M +2.19% | 30.5M +2.05% | 29.9M +1.99% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 236.0M -43.75% | 419.6M +1,059.97% | 36.2M -54.11% | 78.8M -38.20% | |
Short-Term Investments | 347.8M +199.90% | 116.0M +18.82% | 97.6M -27.34% | 134.3M +20.38% | |
Cash and Cash Equivalents and Short-Term Investments | 583.8M +9.00% | 535.6M +300.37% | 133.8M -37.24% | 213.1M -10.87% | |
Total Current Assets | 702.8M +8.82% | 645.8M +179.80% | 230.8M -20.07% | 288.8M -5.48% | |
Accumulated Depreciation | 91.2M +28.04% | 71.2M +41.02% | 50.5M +43.41% | 35.2M +55.11% | |
Property and Plant and Equipment and Net | 151.6M +21.19% | 125.1M +20.15% | 104.1M +37.59% | 75.7M +35.26% | |
Total Long-Term Assets | 44.7M +6.85% | 41.9M -12.88% | 48.0M +115.89% | 22.3M +38.62% | |
Total Assets | 1.0B +9.51% | 931.4M +115.04% | 433.1M -3.36% | 448.2M -3.18% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 18.5M 0.00% | 18.5M N/A | 0 N/A | 0 -100.00% | |
Total Current Liabilities | 151.9M +36.94% | 110.9M +3.31% | 107.4M +20.51% | 89.1M +1.41% | |
Total Long-Term Debt | 649.5M +0.47% | 646.4M +1,749.62% | 35.0M +0.04% | 34.9M +260.53% | |
Total Long-Term Liabilities | 908,000 -89.42% | 8.6M +747.73% | 1.0M -22.57% | 1.3M +87.52% | |
Total Liabilities | 867.3M +3.18% | 840.5M +276.84% | 223.0M +7.02% | 208.4M +13.60% | |
Retained Earnings | -803.4M +5.87% | -758.9M +17.55% | -645.6M +23.63% | -522.2M +28.61% | |
Total Stockholders Equity | 152.7M +68.02% | 90.9M -56.73% | 210.1M -12.39% | 239.8M -14.20% | |
Total Shares Outstanding | 32.3M +2.88% | 31.4M +1.42% | 31.0M +2.52% | 30.2M +2.37% | |
Cash Flow | |||||
Cash from Operating Activities | 80.9M +2,285.34% | 3.4M +106.77% | -50.1M +117.72% | -23.0M -39.05% | |
Capital Expenditures | 46.3M +36.53% | 33.9M -16.04% | 40.4M +35.51% | 29.8M +6.28% | |
Cash from Investing Activities | -277.1M +125.28% | -123.0M +10,072.29% | -1.2M -97.69% | -52.4M -149.81% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 12.6M -97.53% | 511.4M +5,697.97% | 8.8M -66.99% | 26.7M +193.49% | |
Financials Ratio | |||||
Gross Margin | 70.57% +2.48% | 68.86% +2.24% | 67.35% -1.74% | 68.54% +3.60% | |
Operating Margin | -7.68% -60.63% | -19.52% -23.18% | -25.40% -8.26% | -27.69% -10.56% | |
Return on Assets | -4.57% -72.50% | -16.60% -40.71% | -28.00% +9.84% | -25.50% +22.58% | |
Return on Equity | -36.57% -51.42% | -75.27% +37.22% | -54.86% +22.64% | -44.73% +37.06% | |
Revenue Growth | 26.24% +30.38% | 20.13% +1.15% | 19.90% -27.09% | 27.29% +25.50% | |
Current Ratio | 4.63 -20.53% | 5.82 +170.85% | 2.15 -33.67% | 3.24 -6.80% | |
Cash Ratio | 1.55 -58.93% | 3.78 +1,022.86% | 0.34 -61.92% | 0.88 -39.06% | |
Debt-to-Equity Ratio | 4.37 -40.21% | 7.31 +4,295.73% | 0.17 +14.21% | 0.15 +90.71% | |
Debt-to-Assets Ratio | 0.65 -8.26% | 0.71 +784.63% | 0.08 +3.59% | 0.08 +68.98% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow